Friend or foe? Mitochondria as a pharmacological target in cancer treatment

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Mitochondria have acquired numerous functions over the course of evolution, such as those involved in controlling energy production, cellular metabolism, cell survival, apoptosis and autophagy within host cells. Tumor cells can develop defects in mitochondrial function, presenting a potential strategy for designing selective anticancer therapies. Therefore, cancer has been the main focus of recent research to uncover possible mitochondrial targets for therapeutic benefit. This comprehensive review covers not only the recent discoveries of the roles of mitochondria in cancer development, progression and therapeutic implications but also the findings regarding emerging mitochondrial therapeutic targets and mitochondria-targeted agents. Current challenges and future directions for developments and applications of mitochondrial-targeted therapeutics are also discussed.

Original languageEnglish (US)
Pages (from-to)2197-2210
Number of pages14
JournalFuture Medicinal Chemistry
Volume9
Issue number18
DOIs
StatePublished - Dec 1 2017

Fingerprint

Mitochondria
Pharmacology
Neoplasms
Therapeutics
Autophagy
Cell Survival
Apoptosis
Research

Keywords

  • ATAD3A
  • anticancer strategy
  • cancer
  • mitochondria
  • mitochondrial targets

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Friend or foe? Mitochondria as a pharmacological target in cancer treatment. / Dickerson, Tyler; Jauregui, Catherine Ella; Teng, Yong.

In: Future Medicinal Chemistry, Vol. 9, No. 18, 01.12.2017, p. 2197-2210.

Research output: Contribution to journalReview article

@article{ef9e5ab6a73945a2b82ba26a20e19410,
title = "Friend or foe? Mitochondria as a pharmacological target in cancer treatment",
abstract = "Mitochondria have acquired numerous functions over the course of evolution, such as those involved in controlling energy production, cellular metabolism, cell survival, apoptosis and autophagy within host cells. Tumor cells can develop defects in mitochondrial function, presenting a potential strategy for designing selective anticancer therapies. Therefore, cancer has been the main focus of recent research to uncover possible mitochondrial targets for therapeutic benefit. This comprehensive review covers not only the recent discoveries of the roles of mitochondria in cancer development, progression and therapeutic implications but also the findings regarding emerging mitochondrial therapeutic targets and mitochondria-targeted agents. Current challenges and future directions for developments and applications of mitochondrial-targeted therapeutics are also discussed.",
keywords = "ATAD3A, anticancer strategy, cancer, mitochondria, mitochondrial targets",
author = "Tyler Dickerson and Jauregui, {Catherine Ella} and Yong Teng",
year = "2017",
month = "12",
day = "1",
doi = "10.4155/fmc-2017-0110",
language = "English (US)",
volume = "9",
pages = "2197--2210",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "18",

}

TY - JOUR

T1 - Friend or foe? Mitochondria as a pharmacological target in cancer treatment

AU - Dickerson, Tyler

AU - Jauregui, Catherine Ella

AU - Teng, Yong

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Mitochondria have acquired numerous functions over the course of evolution, such as those involved in controlling energy production, cellular metabolism, cell survival, apoptosis and autophagy within host cells. Tumor cells can develop defects in mitochondrial function, presenting a potential strategy for designing selective anticancer therapies. Therefore, cancer has been the main focus of recent research to uncover possible mitochondrial targets for therapeutic benefit. This comprehensive review covers not only the recent discoveries of the roles of mitochondria in cancer development, progression and therapeutic implications but also the findings regarding emerging mitochondrial therapeutic targets and mitochondria-targeted agents. Current challenges and future directions for developments and applications of mitochondrial-targeted therapeutics are also discussed.

AB - Mitochondria have acquired numerous functions over the course of evolution, such as those involved in controlling energy production, cellular metabolism, cell survival, apoptosis and autophagy within host cells. Tumor cells can develop defects in mitochondrial function, presenting a potential strategy for designing selective anticancer therapies. Therefore, cancer has been the main focus of recent research to uncover possible mitochondrial targets for therapeutic benefit. This comprehensive review covers not only the recent discoveries of the roles of mitochondria in cancer development, progression and therapeutic implications but also the findings regarding emerging mitochondrial therapeutic targets and mitochondria-targeted agents. Current challenges and future directions for developments and applications of mitochondrial-targeted therapeutics are also discussed.

KW - ATAD3A

KW - anticancer strategy

KW - cancer

KW - mitochondria

KW - mitochondrial targets

UR - http://www.scopus.com/inward/record.url?scp=85037688901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037688901&partnerID=8YFLogxK

U2 - 10.4155/fmc-2017-0110

DO - 10.4155/fmc-2017-0110

M3 - Review article

VL - 9

SP - 2197

EP - 2210

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 18

ER -